Financials
- Market Capitalization 17.3 B
- Employee 2 000
- Founded 1992
- CEO Kevin C. Gorman
- Website www.neurocrine.com
- Headquarter Delaware, United States
- FIGI BBG000GJS7C1
- Industry 전문의약품 및 제네릭 의약품 제조업체
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
30.37
주가매출액비율
5.08
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 510 | TAK Takeda Pharmaceutical Company Limited American Depositary Share | 16.43 USD | -0.36% | -3.24% | +3.46% | +15.83% | 25.59 B USD | ||
| 616 | VTRS Viatris Inc. - Common Stock | 16.18 USD | -1.28% | -5.10% | -2.53% | +56.33% | 18.84 B USD | ||
| 792 | ELAN Elanco Animal Health Incorporated Common Stock | 25.39 USD | +0.95% | +3.42% | +2.67% | +13.37% | 12.68 B USD | ||
| 877 | RDY Dr. Reddy's Laboratories Ltd | 12.77 USD | -1.16% | -12.77% | -4.63% | -12.95% | 10.66 B USD |